The two updates underscore Teva’s strong execution of its Pivot to Growth strategy and commitment to financial ...

Prague-based Pale Fire Capital SE added 639,162 shares of Teva in the third quarter. As of September 30, the fund reported ...

Corcept Therapeutics faces high binary risk from an imminent Teva lawsuit decision that could impact Korlym sales. Find out ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best affordable healthcare stocks to buy now. Teva ...

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Teva Pharmaceutical Industries wasn’t one of them. The 10 stocks that ...

Teva stock climbs past $30 with strong Austedo and Ajovy sales, but shifting Wall Street sentiment may affect its outlook.

Teva has spent the last few years working to resolve its wide-ranging opioid litigation and finally reached a multibillion-dollar settlement last year. But quietly in the background, a possible ...

Investing.com -- S&P Global Ratings has upgraded Teva Pharmaceutical Industries Ltd. to ’BB+’ from ’BB’ with a stable outlook ...

S&P upgraded Teva to BB+ and Moody's turned positive, citing falling leverage, stronger cash flow, and branded drug momentum that could support a future investment-grade rating.

JERUSALEM (Reuters) - Israel's war with Hamas is not expected to have much impact on Teva Pharmaceutical Industries' business performance, the company said on Tuesday. Teva said sales in Israel ...

Teva Pharmaceuticals will resume producing the vital cancer drug vincristine after a shortage caused a “nightmare situation” for physicians and patients, according to STAT. Vincristine is used to ...

Teva Pharmaceutical Industries, a manufacturer of generic pharmaceutical products, and Russian subsidiary Teva Russia, agreed last week to resolve criminal charges, and to pay a criminal penalty of ...